Contact
Fill in your keyword :
Search
fr
en
Support Us
IGBMC
Missions
History
Support us
Directory
Intranet
Organisation
Boards and committees
News
Latest news
Next events
Prizes and awards
Press review
Scientific publications
Defended theses
Newsletters
Life at IGBMC
Job offers
Student Post-Doc Board
Whistleblowing system
Visiting the IGBMC
Research
Departments
Developmental Biology and Stem Cells
Integrated Structural Biology
Functional Genomics and Cancer
Translational Medicine and Neurogenetics
Executive management
Teams
Subgroups
Topics
Cancer
Rare diseases
Regenerative medicine
Scientific publications
Platforms and services
Research facilities
Centre for integrative biology
Institut clinique de la souris
Platforms
Integrated Structural Biology
CytoEast
Phenotypic analysis and cell screening
Genomeast
PluriCell East
Photonic microscopy
Protéomics
Services
Zebrafish aquatic facility
Rodents house
Baculovirus
Molecular biology and virus
Mediaprep
Training
EUR IMCBio
Internships and thesis
Partnership and innovation
Innovating with IGBMC
Technological expertise
Technology transfer
Start-up
You Are
IGBMC staff members
Home
IGBMC
Thérapie génique ciblée du muscle squelettique : vers un traitement de la myopathie centronucléaire liée à BIN1
Thérapie génique ciblée du muscle squelettique : vers un traitement de la myopathie centronucléaire liée à BIN1
Le
December
16 2025
at
14h00
Thèse
Hosts
Jocelyn LAPORTE
Research team(s)
Pathophysiology of neuromuscular diseases
Location
Auditorium, IGBMC
Speaker
Jacqueline JI
Partager
